Diabetes

Type 2 Diabetes Type 1 Diabetes Treatment Options Management Prediabetes Diabetes Management Medications Complications Treatment Blood Sugar Control

Deloitte Warns GLP-1 Boom Is Inflating Pharma Returns, Concentrating Risk

Heavy bets on obesity drugs increase vulnerability to shocks.

Hershey Links Mint and Gum Sales Jump to GLP-1 Drug Use

Senseonics Prices $80 Million Offering to Fuel Eversense 365 Rollout

FDA Clears First Automated Insulin System for Type 1 Diabetes in Pregnancy

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

AI Study of 400,000 Reddit Posts Flags Underreported GLP-1 Side-Effect Signals

Bret Michaels to Perform at 2026 NFL Draft in Pittsburgh

CVS, FTC Reach Proposed Settlement Over Insulin Pricing

Pre-Packed Diabetes Go-Bags Endorsed in New How-To and Real-World Test

Biomea Fusion Reports Positive 52-Week Phase II Results for Icovamenib in Diabetes

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

Endocrinologist Flags Alarm Issues and Memory Concerns in Daylesford Crash Inquest

New Study Bolsters Case for Early Dinners, With a Three-Hour Pre-Bed Cutoff

GLP-1 Drugs Tied to Lower Addiction Risk and Harms in Large VA Study

GLP-1 Drugs Plus Healthy Habits Linked to Lower Heart Risk in Large VA Diabetes Study

Study Finds Waist-to-Height Ratio Outperforms BMI for Flagging Diabetes Risk in U.S. Youth

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Red Meat, Diabetes Risk, and a Hypoxia-Inspired Therapy: New Findings

Electronic Mesh Speeds Maturation of Lab-Grown Islet Cells in Peer-Reviewed Study

Eating Earlier and Extending Overnight Fasts Show Short-Term Heart and Metabolic Gains